{"database": "openregs", "table": "documents", "rows": [["FDA-2013-D-1319-0015", "FDA", "FDA-2013-D-1319", "Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2026-05-11T04:00:00Z", 2026, 5, "2026-05-11T04:00:00Z", null, "2026-05-11T17:27:37Z", "2026-09269", 0, 0, "09000064b92cf98a"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-D-1319-0015"], "units": {}, "query_ms": 0.5708078388124704, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}